[1] |
严芳, 严永东. 儿童塑型性支气管炎的诊治进展[J]. 国际儿科学杂志, 2021, 48(11): 737-740.
|
[2] |
胡晓光, 张海邻. 儿童塑型性支气管炎的常见病因及致病机制[J]. 中华实用儿科临床杂志, 2021, 36(4): 244-247.
|
[3] |
翟嘉, 邹映雪, 张文双, 等. 儿童塑型性支气管炎53例临床回顾分析[J]. 中国实用儿科杂志, 2016, 31(3): 211-214.
|
[4] |
蔡利红, 李双双, 屈春燕, 等. 儿童肺炎后发生塑型性支气管炎的临床特征性表现及支气管镜诊治价值[J]. 中华实用儿科临床杂志, 2020, 35(21): 1638-1642.
|
[5] |
中华人民共和国国家卫生健康委员会国家中医药管理局. 儿童腺病毒肺炎诊疗规范( 2019年版)[J]. 中华临床感染病杂志, 2019, 3: 161-166.
|
[6] |
黄晶晶, 袁林, 卓志强, 等. 儿童腺病毒肺炎并塑型性支气管炎9例临床分析[J]. 中华实用儿科临床杂志, 2020, 35(16): 1260-1263.
|
[7] |
van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system[J]. J Pathol, 2015, 235(2): 277-287.
|
[8] |
刘爱良, 黄英, 杨洋, 等. 儿童重症腺病毒肺炎213例临床特征分析[J]. 临床儿科杂志, 2013, 31(8): 726-729.
|
[9] |
Zeng L, Wei J, Tang Y, et al. Clinical characteristics of human adenovirus plastic bronchitis in 10 pediatric cases: a retrospective study of seven years[J]. Virol Sin, 2021, 36(3): 550-554.
|
[10] |
Zhang FZ, Qin L, Yuan JX, et al. Plastic bronchitis due to adenoviral infection: a case report[J]. BMC Pediatr, 2020, 20(1): 61.
doi: 10.1186/s12887-020-1954-0
pmid: 32039717
|
[11] |
Huang JJ, Yang XQ, Zhuo ZQ, et al. Clinical characteristics of plastic bronchitis in children: a retrospective analysis of 43 cases[J]. Respir Res, 2022, 23(1): 51.
|
[12] |
陈伟, 周浩泉. 重症腺病毒肺炎患儿生化指标表达水平及近期预后危险因素研究[J]. 临床肺科杂志, 2021, 26(3): 335-339.
|
[13] |
刘秀平, 王咏梅. 儿童重症腺病毒肺炎危险因素分析及乳酸脱氢酶在重症腺病毒肺炎中的诊断价值研究[J]. 中国医学创新, 2021, 18(6): 68-72.
|
[14] |
Hou Y, Liu J, Li Y, et al. Study on the changes and significance of immune state and cycokines in children with adenovirus pneumonia[J]. Evid Based Complement Alternat Med, 2022, 2022: 2419454.
|
[15] |
Fu Y, Tang Z, Ye Z, et al. Human adenovirus type 7 infection causes a more severe disease than type 3[J]. BMC Infect Dis, 2019, 19(1): 36.
doi: 10.1186/s12879-018-3651-2
pmid: 30626350
|
[16] |
Peng L, Liu S, Xie T, et al. Predictive value of adenoviral load for bronchial mucus plugs formation in children with adenovirus pneumonia[J]. Can Respir J, 2022, 2022: 9595184.
|
[17] |
Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children[J]. Pediatrics, 2002, 110(1 Pt 1): e9.
|
[18] |
Pal P, Bose N, Poddar A, et al. Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis[J]. Clin Rheumatol, 2020, 39(8): 2449-2452.
doi: 10.1007/s10067-020-05133-0
pmid: 32418043
|
[19] |
黄浩, 陈瑜, 马丽娅, 等. 儿童重症腺病毒肺炎的临床特征及高危因素分析[J]. 中华儿科杂志, 2021, 59(1): 4-19.
|